72.48
-3.03
(-4.01%)
At close: 5:42:35 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 26 | 27 |
| Avg. Estimate | 2.5B | 2.58B | 10.45B | 10.93B |
| Low Estimate | 2.45B | 2.54B | 10.32B | 10.64B |
| High Estimate | 2.51B | 2.6B | 10.49B | 11.09B |
| Year Ago Sales | 2.47B | 2.49B | 10.13B | 10.45B |
| Sales Growth (year/est) | 1.25% | 3.64% | 3.23% | 4.58% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0ILW.L | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Baird: Neutral to Neutral | 4/4/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/18/2025 |
| Maintains | UBS: Neutral to Neutral | 2/12/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 2/12/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/12/2025 |
| Downgrade | Susquehanna: Positive to Neutral | 2/12/2025 |